BIM
ABBV icon

Baldwin Investment Management’s AbbVie ABBV Stock Holding History

Baldwin Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.19M Sell
28,449
-100
-0.4% -$22.2K 0.72% 18
2025
Q4 		$6.52M Sell
28,549
-431
-1% -$98.2K 0.74% 17
2025
Q3 		$6.71M Buy
28,980
+450
+2% +$91.6K 0.77% 15
2025
Q2 		$5.3M Buy
28,530
+625
+2% +$116K 0.64% 20
2025
Q1 		$5.85M Buy
27,905
+372
+1% +$72.3K 0.7% 16
2024
Q4 		$4.89M Sell
27,533
-2,918
-10% -$536K 0.64% 19
2024
Q3 		$6.01M Sell
30,451
-1,017
-3% -$190K 0.75% 13
2024
Q2 		$5.4M Buy
31,468
+150
+0.5% +$24.8K 0.74% 17
2024
Q1 		$5.7M Buy
31,318
+250
+0.8% +$43.1K 0.77% 14
2023
Q4 		$4.81M Sell
31,068
-1,525
-5% -$222K 0.75% 17
2023
Q3 		$4.86M Sell
32,593
-558
-2% -$81.9K 0.81% 12
2023
Q2 		$4.47M Sell
33,151
-3,445
-9% -$505K 0.74% 15
2023
Q1 		$5.83M Sell
36,596
-1,394
-4% -$213K 1.03% 6
2022
Q4 		$6.14M Sell
37,990
-960
-2% -$147K 1.11% 5
2022
Q3 		$5.23K Sell
38,950
-1,752
-4% -$251K 1.06% 4
2022
Q2 		$6.23K Sell
40,702
-1,912
-4% -$292K 1.18% 4
2022
Q1 		$6.91K Sell
42,614
-1,740
-4% -$253K 1.05% 5
2021
Q4 		$6.01K Buy
44,354
+101
+0.2% +$11.9K 0.94% 8
2021
Q3 		$4.77M Buy
44,253
+210
+0.5% +$24K 0.83% 13
2021
Q2 		$4.96M Sell
44,043
-324
-0.7% -$36.5K 0.84% 11
2021
Q1 		$4.8M Buy
44,367
+272
+0.6% +$29.1K 0.88% 10
2020
Q4 		$4.72M Buy
44,095
+4,411
+11% +$424K 0.93% 10
2020
Q3 		$3.48M Buy
39,684
+10,940
+38% +$1.03M 0.81% 16
2020
Q2 		$2.82M Buy
28,744
+851
+3% +$74.9K 0.89% 11
2020
Q1 		$2.13M Hold
27,893
– – 0.73% 18
2019
Q4 		$2.47M Sell
27,893
-50
-0.2% -$4.15K 0.66% 20
2019
Q3 		$2.12M Buy
27,943
+775
+3% +$53.1K 0.62% 20
2019
Q2 		$1.98M Buy
27,168
+50
+0.2% +$3.93K 0.57% 21
2019
Q1 		$2.19M Buy
27,118
+150
+0.6% +$12.3K 0.66% 17
2018
Q4 		$2.49M Sell
26,968
-200
-0.7% -$17.6K 0.79% 9
2018
Q3 		$2.57M Buy
27,168
+975
+4% +$92.5K 0.74% 12
2018
Q2 		$2.43M Buy
26,193
+8,363
+47% +$817K 0.76% 12
2018
Q1 		$1.69M Buy
17,830
+100
+0.6% +$11K 0.6% 21
2017
Q4 		$1.72M Sell
17,730
-250
-1% -$23.6K 0.61% 16
2017
Q3 		$1.6M Sell
17,980
-212
-1% -$16.1K 0.6% 16
2017
Q2 		$1.32M Sell
18,192
-625
-3% -$42K 0.53% 23
2017
Q1 		$1.23M Hold
18,817
– – 0.47% 32
2016
Q4 		$1.18M Sell
18,817
-375
-2% -$22.9K 0.47% 26
2016
Q3 		$1.21M Sell
19,192
-300
-2% -$19.4K 0.52% 27
2016
Q2 		$1.21M Sell
19,492
-443
-2% -$27K 0.52% 29
2016
Q1 		$1.14M Sell
19,935
-3
-0% -$167 0.49% 29
2015
Q4 		$1.18M Sell
19,938
-197
-1% -$11.3K 0.53% 26
2015
Q3 		$1.1M Hold
20,135
– – 0.48% 27
2015
Q2 		$1.35M Buy
20,135
+985
+5% +$64.3K 0.56% 26
2015
Q1 		$1.12M Buy
19,150
+375
+2% +$22.7K 0.44% 33
2014
Q4 		$1.23M Hold
18,775
– – 0.48% 30
2014
Q3 		$1.08M Buy
18,775
+350
+2% +$19.4K 0.45% 34
2014
Q2 		$1.04M Buy
18,425
+1,325
+8% +$69.5K 0.45% 32
2014
Q1 		$879K Hold
17,100
– – 0.39% 37
2013
Q4 		$903K Hold
17,100
– – 0.41% 36
2013
Q3 		$765K Sell
17,100
-350
-2% -$15.5K 0.37% 44
2013
Q2 		$721K Buy
+17,450
New +$763K 0.36% 46

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baldwin Investment Management's ABBV Position: Q1 2026 in Review

Baldwin Investment Management reduced its AbbVie (ABBV) stake by 0.35% in Q1 2026, selling an estimated $22.2K and leaving 28,449 shares worth $6.19M. The position accounts for 0.72% of the portfolio, ranked #18.

Baldwin Investment Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.71M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Baldwin Investment Management held 28,449 shares of AbbVie worth $6.19M as of Q1 2026.
  • Baldwin Investment Management sold 100 AbbVie shares in Q1 2026, an estimated $22.2K.
  • AbbVie made up 0.72% of Baldwin Investment Management's portfolio in Q1 2026, its #18 holding.
  • Baldwin Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Baldwin Investment Management's AbbVie position peaked at $6.71M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Baldwin Investment Management's 13F filing for Q1 2026, filed 12 May 2026.